Funder: National Institutes of Health
Due Dates: December 1, 2030 (Application closing date)
Funding Amounts: $6,000,000 estimated total program funding; 4 awards expected
Summary: Supports translational development of next-generation diagnostic and therapeutic devices toward readiness for first-in-human trials within NIH BRAIN and HEAL initiative missions.
Key Information: Clinical trials are not allowed under this R18 opportunity.
Description
This National Institutes of Health opportunity supports investigators advancing next-generation technologies to prevent, monitor, diagnose, and treat disorders within the missions of the Brain Research through Advancing Innovative Neurotechnologies (BRAIN) and Helping to End Addiction Long-term (HEAL) initiatives. The program focuses on translating new devices toward readiness for first-in-human clinical trials, rather than conducting those trials.
Supported work includes technology development and optimization, along with studies preparing devices for approvals for human use. Projects should overcome key challenges identified during preliminary proof-of-concept studies, helping move promising technologies toward clinical translation.
